cdmo.directory
← Compare landing

CatSci vs Sterling Pharma Solutions

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCatSciSterling Pharma Solutions
SummaryUK-based partner for small molecule and complex synthetic medicines, offering route selection, process development, GMP drug substance manufacture and analytical services across four European and UK sites.Small molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.
Services
  • Medicinal Chemistry
  • Analytical Method Development & Validation
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Peptide Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Oligonucleotide
  • Peptide
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Peptide
Development capabilities
  • Analytical method development
  • Solid-state characterization
  • Analytical method development
  • Solid-state characterization
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Substance (DS)
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • DEA licensed
  • Flow Chemistry
LocationsData not yet provided.
  • Cork, Cork, Munster, Ireland
  • Cramlington, Cramlington, Northumberland, United Kingdom
  • Deeside, Deeside, Wales, United Kingdom
  • Newcastle Biosphere, Newcastle, Tyne and Wear, United Kingdom
  • North Carolina, North Carolina, North Carolina, United States
  • Wisconsin, Wisconsin, Wisconsin, United States
  • North Carolina, North Carolina, North Carolina, US
  • Wisconsin, Wisconsin, Wisconsin, US
  • Newcastle Biosphere, Newcastle, England, UK
  • North Carolina, North Carolina, US
  • Wisconsin, Wisconsin, US
  • Cramlington, Cramlington, England, UK
  • North Carolina, North Carolina, North Carolina, USA
  • Wisconsin, Wisconsin, Wisconsin, USA
CertificationsData not yet provided.
  • FDA · Identifier: cGMP inspection
  • HPRA · Identifier: cGMP inspection (mutually recognised by FDA)
  • PMDA · Identifier: Project specific inspection
  • ANVISA · Identifier: Project specific inspection
  • MHRA · Identifier: cGMP inspection
  • DEA · Identifier: Schedule I-V controlled substances approval
  • ISO · Identifier: ISO/IEC 27001:2022, ISO/IEC 9001:2015, ISO 45001:2018, ISO 14001:2015
  • FDA · Identifier: cGMP inspection January 2017
  • PMDA · Identifier: project specific inspection June 2022
  • HPRA · Identifier: cGMP inspection March 2022
  • ANVISA · Identifier: project specific inspection 2021
  • MHRA · Identifier: cGMP inspection June 2021
  • FDA · Identifier: cGMP inspection May 2018
  • MHRA · Identifier: cGMP inspection April 2023
  • FDA · Identifier: Registered as bulk API manufacturer
  • DEA · Identifier: Approved to import, store, manufacture and export Schedule I-V controlled substances
  • FDA · Identifier: cGMP inspection March 2024
  • cGMP · Identifier: cGMP accreditation

Find similar companies

CatSci alternatives · Sterling Pharma Solutions alternatives

Markdown mirror: /compare/catsci/sterlingpharmasolutions.md